Related Experiment Video
Updated: Oct 12, 2025

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum
Francisco J Padilla-Godínez1,2, Rodrigo Ramos-Acevedo1,2, Hilda Angélica Martínez-Becerril1,2
1Neurosciences Division, Cell Physiology Institute, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Cellular dysfunction causes protein misfolding and aggregation in diseases like Parkinson's disease (PD) and endoplasmic reticulum storage disorders (ERSDs). Understanding these shared mechanisms may reveal common therapeutic strategies for these distinct conditions.
Area of Science:
- Molecular Biology
- Neuroscience
- Genetics
Background:
- Cellular homeostasis dysfunction leads to protein misfolding and pathological aggregation.
- This process is implicated in neurodegenerative diseases like Parkinson's disease (PD) and endoplasmic reticulum storage disorders (ERSDs), including alpha-1-antitrypsin deficiency (AATD) and hereditary hypofibrinogenemia with hepatic storage (HHHS).
Purpose of the Study:
- To review the pathological basis of protein misfolding and aggregation in PD, AATD, and HHHS.
- To examine the link between protein aggregation and endoplasmic reticulum (ER) stress in these diseases.
- To compare proteostasis and homeostasis regulation mechanisms and explore potential common therapeutic strategies.
Main Methods:
- Literature review of pathological mechanisms.
- Analysis of protein aggregation in alpha-synuclein (PD), alpha-1-antitrypsin (AATD), and fibrinogen (HHHS).
- Comparison of ER stress responses, unfolded protein response, and autophagy.
Main Results:
- Identified shared pathophysiological pathways in protein misfolding and aggregation across diverse diseases.
- Highlighted the role of ER stress and proteostasis dysfunction in PD, AATD, and HHHS.
- Demonstrated similarities in cellular defense mechanisms like the unfolded protein response and autophagy.
Conclusions:
- Despite varied symptoms, PD and ERSDs share underlying mechanisms of protein misfolding and aggregation.
- Targeting these common pathways, particularly ER stress and proteostasis, offers potential for novel, shared therapeutic approaches.
More Related Videos
Related Concept Videos
Lysosomal Hydrolases
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Parkinson's Disease: Overview
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Export of Misfolded Proteins out of the ER

